Fig. 3From: Shotgun proteomics coupled to nanoparticle-based biomarker enrichment reveals a novel panel of extracellular matrix proteins as candidate serum protein biomarkers for early-stage breast cancer detectionSerum protein levels measured by LC-MRM in the validation set. Normalized AUC values are shown for proteins in models 1 and 2 (cases = 19, white; controls = 41, gray). Adjusted p values were obtained using the Benjamini-Hochberg correction. ANLPQSFQVDTSK (FLNA, adjusted p value = 0.67); HTFMGVVSLGSPSGEVSHPR (AHSG, adjusted p value = 0.84); LAQAAQSSVATITR (TLN1, adjusted p value = 0.0019); LGGSAVISLEGKPL (CFL1, adjusted p value = 8.29E−5); LVVLGSGGVGK (RAP1A, p value = 0.34); SPFSVAVSPSLDLSK (FLNA, p value = 0.58) and VYLFLQPR (ITGA2B, p value = 0.69)Back to article page